Literature DB >> 1925252

Immunotherapy of breast cancer: a review of the development of cell-specific therapy.

G H Lytle1.   

Abstract

A brief history of immunotherapy for breast cancer is presented, with emphasis on how theories developed as the field of immunology became more sophisticated. Non-specific therapies, such as Bacillus Calmette-Guérin, levamisole, interferon, interleukin, and others are reviewed. A form of cell-specific immunotherapy is then presented, and some current results are summarized. Problems and proposals for the future development of immunotherapy for breast cancer are then presented.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1925252     DOI: 10.1002/ssu.2980070406

Source DB:  PubMed          Journal:  Semin Surg Oncol        ISSN: 1098-2388


  2 in total

Review 1.  Human gammadelta-T cells in adoptive immunotherapy of malignant and infectious diseases.

Authors:  Richard D Lopez
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  Natural killer cell activity, phagocytosis, and number of peripheral blood cells in breast cancer patients treated with tamoxifen.

Authors:  J Lukac; Z Kusić; D Kordić; M Koncar; A Bolanca
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.